Drug search by name

Antihemophilic Factor (Recombinant) (Recombinate) and Dacomitinib

Determining the interaction of Antihemophilic Factor (Recombinant) (Recombinate) and Dacomitinib and the possibility of their joint administration.

Check result:

Antihemophilic Factor (Recombinant) (Recombinate) <> Dacomitinib

Relevance: 26.08.2022 Reviewer: Shkutko P.M., M.D., in

No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.

Antihemophilic Factor (Recombinant) (Recombinate)

Generic Name: antihemophilic factor

Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur

Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)

What is Antihemophilic Factor (Recombinant) (Recombinate)?

Dacomitinib

Generic Name: dacomitinib

Brand name: Vizimpro

Synonyms: n.a.

What is Dacomitinib?

+ Add a drug Remove all

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

The list of popular interactions